VANGUARD GROUP INC - CYCLO THERAPEUTICS INC ownership

CYCLO THERAPEUTICS INC's ticker is CYTH and the CUSIP is 23254X201. A total of 16 filers reported holding CYCLO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of CYCLO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$400,478
-3.3%
282,027
+8.3%
0.00%
Q2 2023$413,999
+94.1%
260,377
+2.6%
0.00%
Q1 2023$213,286
-40.8%
253,8820.0%0.00%
Q4 2022$360,512
-26.4%
253,882
+0.0%
0.00%
Q3 2022$490,000
-2.0%
253,7650.0%0.00%
Q2 2022$500,000
-38.1%
253,765
-0.5%
0.00%
Q1 2022$808,000
-14.8%
255,065
+0.3%
0.00%
Q4 2021$948,000
-18.2%
254,301
+48.1%
0.00%
Q3 2021$1,159,000
-25.2%
171,681
+13.3%
0.00%
Q2 2021$1,550,000
+461.6%
151,540
+350.4%
0.00%
Q1 2021$276,00033,6450.00%
Other shareholders
CYCLO THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
XTX Topco Ltd 12,900$18,3180.00%
Virtu Financial LLC 10,732$150.00%
Tower Research Capital LLC (TRC) 6,767$9,6090.00%
JPMORGAN CHASE & CO 240$3410.00%
ROYAL BANK OF CANADA 746$1,0000.00%
VANGUARD GROUP INC 282,027$400,4780.00%
UBS Group AG 88$1250.00%
IFP Advisors, Inc 13$180.00%
OSAIC HOLDINGS, INC. 600$8520.00%
WELLS FARGO & COMPANY/MN 2,352$3,3400.00%
View complete list of CYCLO THERAPEUTICS INC shareholders